IFC Advisory is delighted to be working with Midatech Pharma (LSE AIM: MTPH; NASDAQ: MTP) Midatech is an R&D company focused on delivering innovative oncology and rare disease products to patients. The Company is developing a range of improved chemo-therapeutics or new immuno-therapeutics, using its three-proprietary platform drug delivery technologies, all of which are in the clinic.
Client Appointment
Midatech Pharma Appointment
22
Mar
Mar
IFC appointed by Renold plc
Renold plc (AIM: RNO) has appointed IFC as its financial public relations and investor relations [...]
Mar
Belvedere Leisure Resorts plc Appointment
Belvedere Leisure Resorts plc has appointed IFC Advisory as its financial public relations and investor [...]
Jan
Remote Monitored Systems appoints IFC
Remote Monitored Systems plc (AIM: RMS) has appointed IFC as its financial public relations and [...]
Jan